Fig. 1From: Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMTSurvival of 2780 adults transplanted for ALL after myeloablative conditioning. Kaplan-Meier curves show estimates of leukemia-free survival (LFS, left) and overall survival (OS, right). Curves for patients with undetectable MRD (MRD neg) at transplantation are shown in full lines, and for MRD-positive (MRD pos) patients in broken lines. Curves related to TBI-based conditioning are shown black and to chemotherapy-based conditioning in gray linesBack to article page